Table 1.
All ophthalmologists | University hospital ophthalmologists | Nonacademic hospital ophthalmologists | Clinic ophthalmologists | |
---|---|---|---|---|
Number of ophthalmologists in the institution | ||||
≥11 | 6 | 6 | 0 | 0 |
6–10 | 3 | 0 | 2 | 1 |
1–5 | 9 | 1 | 5 | 3 |
Number of ophthalmologists trained for intravitreal injections | ||||
≥11 | 2 | 2 | 0 | 0 |
5–10 | 2 | 2 | 0 | 0 |
2–4 | 10 | 3 | 6 | 1 |
1 | 4 | 0 | 1 | 3 |
Institution size (bed count) | ||||
≥1,000 | 3 | 3 | 0 | 0 |
500–999 | 5 | 3 | 2 | 0 |
20–499 | 5 | 0 | 5 | 0 |
Unknown or ≤19 | 5 | 1 | 0 | 4 |
Payment method | ||||
DPCa | 14 | 7 | 7 | 0 |
Non-DPC | 4 | 0 | 0 | 4 |
Designated treatment location for anti-VEGF injections | ||||
Outpatient treatment rooms | 7 | 5 | 1 | 1 |
Operating rooms | 9 | 1 | 6 | 2 |
Both | 2 | 1 | 0 | 1 |
Need to reserve space to perform anti-VEGF injections | ||||
Necessary | 10 | 2 | 7 | 1 |
Unnecessary | 8 | 5 | 0 | 3 |
Note:
An inpatient bundle payment system similar to the diagnosis-related groups used in Medicare in the US.
Abbreviations: anti-VEGF, anti-vascular endothelial growth factor; DPC, diagnosis procedure combination.